Villamor, Erlinda N.
HRN: 20-49-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/25/2022
07/02/2022
IV
4.5gram As LD
As Loading Dose
Septicemia
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes